Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms

Advances and Applications in Bioinformatics and Chemistry

Volumn 1, Issue 1, 2008, Pages 29-50

  Kim, Hyeon O ^a   Snyder, Greg P ^a   Blazey, Tyler M ^a   Race, Richard E ^b   Chesebro, Bruce ^b   Skinner, Pamela J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Gene expression; Microarrays; Prion disease

Indexed keywords

ANIMALIA; MUS;

EID: 78651372944     PISSN: None     EISSN: 11786949     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Aguzzi A, Heikenwalder M. 2005. Prions, cytokines, and chemokines: a meeting in lymphoid organs. Immunity, 22:145-54.
2. Aguzzi A, Polymenidou M. 2004. Mammalian prion biology: one century of evolving concepts. Cell, 116:313-27.
3. Aguzzi A. 2006. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem, 97:1726-39.
4. Andreoletti O, Berthon P, Marc D, et al. 2000. Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol, 81(Pt 12):3115-26.
5. Baker CA, Lu ZY, Manuelidis L. 2004. Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease. J Neurovirol, 10:29-40.
6. Baker CA, Lu ZY, Zaitsev I, et al. 1999. Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol, 73:5089-97.
7. Baker CA, Manuelidis L. 2003. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A, 100:675-9.
8. Baker CA, Martin D, Manuelidis L. 2002. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol, 76:10905-13.
9. Baker M, Mackenzie IR, Pickering-Brown SM, et al. 2006. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 442:916-9.
10. Bartz JC, Kincaid AE, Bessen RA. 2003. Rapid prion neuroinvasion following tongue infection. J Virol, 77:583-91.
11. Belay ED, Maddox RA, Williams ES, et al. 2004. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis, 10:977-84.
12. Booth S, Bowman C, Baumgartner R, et al. 2004a. Molecular classification of scrapie strains in mice using gene expression profiling. Biochem Biophys Res Commun, 325:1339-45.
13. Booth S, Bowman C, Baumgartner R, et al. 2004b. Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J Gen Virol, 85(Pt 11):3459-71.
14. Brown AR, Webb J, Rebus S, et al. 2004. Identification of up-regulated genes by array analysis in scrapie-infected mouse brains. Neuropathol Appl Neurobiol, 30:555-67.
15. Bruce ME, Fraser H. 1991. Scrapie strain variation and its implications. Curr Top Microbiol Immunol, 172:125-38.
16. Bruce ME, Will RG, Ironside JW, et al. 1997. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature, 389:498-501.
17. Budka H, Aguzzi A, Brown P, et al. 1995. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol, 5:459-66.
18. Caughey B, Raymond GJ, Ernst D, et al. 1991. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol, 65:6597-603.
19. Caughey B, Raymond GJ. 1991. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive. J Biol Chem, 266:18217-23.
20. Caughey B. 1993. Scrapie associated PrP accumulation and its prevention: insights from cell culture. Br Med Bull, 49:860-72.
21. Chandler RL. 1963. Experimental scrapie in the mouse. Res Vet Sci, 4:276.
22. Chesebro B. 2003. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull, 66:1-20.
23. Cruts M, Gijselinck I, van der Zee J, et al. 2006. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 442:920-4.
24. Dandoy-Dron F, Guillo F, Benboudjema L, et al. 1998. Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem, 273:7691-7.
25. Dickinson AG. 1976. Scrapie in sheep and goats. Front Biol, 44:209-41.
26. Diedrich JF, Carp RI, Haase AT. 1993. Increased expression of heat shock protein, transferrin, and beta 2-microglobulin in astrocytes during scrapie. Microb Pathog, 15:1-6.
27. Diehn M, Sherlock G, Binkley G, et al. 2003. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res, 31:219-23.
28. Doh-Ura K, Iwaki T, Caughey B. 2000. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol, 74:4894-7.
29. Doh-ura K, Mekada E, Ogomori K, et al. 2000. Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies. J Neuropathol Exp Neurol, 59:774-85.
30. Dormont D, Delpech B, Delpech A, et al. 1981. [Hyperproduction of glial fibrillary acidic protein (GFA) during development of experimental scrapie in mice]. C R Seances Acad Sci III, 293:53-6.
31. Duguid J, Trzepacz C. 1993. Major histocompatibility complex genes have an increased brain expression after scrapie infection. Proc Natl Acad Sci U S A, 90:114-7.
32. Duguid JR, Dinauer MC. 1990. Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in scrapie infection. Nucleic Acids Res, 18:2789-92.
33. Duguid JR, Rohwer RG, Seed B. 1988. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci U S A, 85:5738-42.
34. Evert BO, Vogt IR, Vieira-Saecker AM, et al. 2003. Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol, 62:1006-18.
35. Fraser H, Dickinson AG. 1970. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature, 226:462-3.
36. Gayrard V, Picard-Hagen N, Grino M, et al. 2000. Major hypercorticism is an endocrine feature of ewes with naturally occurring scrapie. Endocrinology, 141:988-94.
37. Glock B, Winter M, Rennhofer SO, et al. 2003. Transcript level of erythroid differentiation-related factor, a candidate surrogate marker for transmissible spongiform encephalopathy diseases in blood, shows a broad range of variation in healthy individuals. Transfusion, 43:1706-10.
38. Greenwood AD, Horsch M, Stengel A, et al. 2005. Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J Mol Biol, 349:487-500.
39. Harvey S, Hull K. 2003. Neural growth hormone: an update. J Mol Neurosci, 20:1-14.
40. Harvey S, Kakebeeke M, Murphy AE, et al. 2003. Growth hormone in the nervous system: autocrine or paracrine roles in retinal function? Can J Physiol Pharmacol, 81:371-84.
41. Hunter GD, Kimberlin RH, Millson GC. 1972. Absence of eclipse phase in scrapie mice. Nat New Biol, 235:31-2.
42. Kaplan JH. 2002. Biochemistry of Na,K-ATPase. Annu Rev Biochem, 71:511-35.
43. Kascsak RJ, Rubenstein R, Carp RI. 1991. Evidence for biological and structural diversity among scrapie strains. Curr Top Microbiol Immunol, 172:139-52.
44. Kopacek J, Sakaguchi S, Shigematsu K, et al. 2000. Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J Virol, 74:411-7.
45. Lengacher S, Magistretti PJ, Pellerin L. 2004. Quantitative rt-PCR analysis of uncoupling protein isoforms in mouse brain cortex: methodological optimization and comparison of expression with brown adipose tissue and skeletal muscle. J Cereb Blood Flow Metab, 24:780-8.
46. Liu L, Askari A. 2006. Beta-subunit of cardiac Na+-K+-ATPase dictates the concentration of the functional enzyme in caveolae. Am J Physiol Cell Physiol, 291:C569-78.
47. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25:402-8.
48. Lu ZY, Baker CA, Manuelidis L. 2004. New molecular markers of early and progressive CJD brain infection. J Cell Biochem, 93:644-52.
49. Manuelidis L, Tesin DM, Sklaviadis T, et al. 1987. Astrocyte gene expression in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A, 84:5937-41.
50. Matilla A, Koshy BT, Cummings CJ, et al. 1997. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature, 389:974-8.
51. Matilla A, Radrizzani M. 2005. The Anp32 family of proteins containing leucine-rich repeats. Cerebellum, 4:7-18.
52. McKinley MP, Bolton DC, Prusiner SB. 1983. A protease-resistant protein is a structural component of the scrapie prion. Cell, 35:57-62.
53. McKinley MP, Taraboulos A, Kenaga L, et al. 1961. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest, 65:622-30.
54. Miele G, Manson J, Clinton M. 2001. A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med, 7:361-4.
55. Mukherjee O, Pastor P, Cairns NJ, et al. 2006. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol, 60:314-22.
56. Opal P, Garcia JJ, Propst F, et al. 2003. Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. J Biol Chem, 278:34691-9.
57. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-44.
58. Rangon CM, Haik S, Faucheux BA, et al. 2003. Different chromogranin immunoreactivity between prion and a-beta amyloid plaque. Neuroreport, 14:755-8.
59. Riemer C, Neidhold S, Burwinkel M, et al. 2004. Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun, 323:556-64.
60. Riemer C, Queck I, Simon D, et al. 2000. Identification of upregulated genes in scrapie-infected brain tissue. J Virol, 74:10245-8.
61. Rodriguez A, Perez-Gracia E, Espinosa JC, et al. 2006. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Acta Neuropathol (Berl), 112:573-85.
62. Schultz J, Schwarz A, Neidhold S, et al. 2004. Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol, 165:671-8.
63. Skinner PJ, Abbassi H, Chesebro B, et al. 2006. Gene expression alterations in brains of mice infected with three strains of scrapie. BMC Genomics, 7:114.
64. Storey J. 2002. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol, 64:479-98.
65. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A, 98:5116-21.
66. van Keulen LJ, Schreuder BE, Vromans ME, et al. 2000. Pathogenesis of natural scrapie in sheep. Arch Virol Suppl, (16):57-71.
67. Viguie C, Chilliard Y, Gayrard V, et al. 2004. Alterations of somatotropic function in prion disease in sheep. J Endocrinol, 183:427-35.
68. Vorberg I, Raines A, Priola SA. 2004. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem, 279:29218-25.
69. Weissmann C. 2004. The state of the prion. Nat Rev Microbiol, 2:861-71.
70. Wells GA. 1993. Pathology of nonhuman spongiform encephalopathies: variations and their implications for pathogenesis. Dev Biol Stand, 80:61-9.
71. Williams AE, Lawson LJ, Perry VH, et al. 1994. Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol, 20:47-55.
72. Xiang W, Windl O, Wunsch G, et al. 2004. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol, 78:11051-60.
73. Ye X, Carp RI. 1996. Histopathological changes in the pituitary glands of female hamsters infected with the 139H strain of scrapie. J Comp Pathol, 114:291-304.
74. Zhang Y, Spiess E, Groschup MH, et al. 2003. Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J Gen Virol, 84(Pt 8):2279-83.
75. Zlotnik I, Rennie JC. 1963. Further observations on the experimental transmission of scrapie from sheep and goats to laboratory mice. J Comp Pathol, 73:150-62.